F-PSMA PET/CT in patients with RCC. The majority report a single clinical case, while only one paper was based on a collection of more than one patient. The first case was published in 2014 (Demerci et al. [3] ) and demonstrated the superiority of 68 Ga-PSMA for the detection of metastases, particularly in the bone, in a patient with RCC. Similarly, Rowe et al. [4] The only large experience, performed in only eight patients, was made by Siva et al. [2] who evaluated the impact of 68 Ga-PSMA PET/CT for the detection of oligometastatic RCC patients who can be treated with local therapies. The authors demonstrated that PSMA was able to better assess the presence of metastatic lesions in lungs, adrenal glands and bone, than 18 F-FDG PET/CT. Moreover, they found that PSMA was able to monitor the response to therapy, thus opening the opportunity to use this receptorial tracer for the evaluation of response to new cytostatic agents (i.e., immunotherapy).
The behavior of radiopharmaceutical agents in recurrent RCC, however, depends on histopathology [6] . In fact, while clear cell RCC has a low glucose metabolism, thus demonstrating a high 68 Ga-PSMA uptake, metastatic sarcomatoid RCC shows a high glucose metabolism (therefore, a high 18 F FDG uptake). Therefore, the choice between 68 Ga/ 18 F-PSMA and 18 F-FDG PET/CT is strongly correlated with the differentiation of the primary and metastatic lesions.
From these preliminary results, some considerations should be kept in mind:
1.
68 Ga/ 18 F-PSMA PET/CT represents a potential useful imaging technique in patients affected by recurrent RCC, being able to detect metastasis and to guide the choice of specific treatments; 2.
68 Ga/ 18 F-PSMA PET/CT could be used for the evaluation of response to new therapeutic agents (i.e., tyrosinekinase inhibitors or immunotherapy); However, the scarce evidence and the limited value of single-patient studies should be further confirmed by studies with a large number of patients. In our opinion, multicenter trials are warranted to confirm the above-mentioned assumptions.
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